|

MK-1167 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Merck Sharp & Dohme LLC1

Indications

  • Alzheimer's Disease1
  • Dementia1
  • Alzheimer Disease1

Phoenix, Arizona1 trial

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Banner Alzheimer's Institute ( Site 0110)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.